| Literature DB >> 31907343 |
Hong-Tian Zhang1,2, Li-Hua Chen1,2, Ru-Xiang Xu1,2.
Abstract
<strong>BACKGROUND</strong> This case series study evaluated the outcome and effect of portable 3D-head computed tomography (CT, MCT-I, 16 rows mobile CT made in China) navigation-guided key-hole microsurgery for supratentorial hypertensive hematomas. <strong>MATERIAL AND METHODS</strong> Thirty-five consecutive unconscious patients with a significant volume of hypertensive intracranial hemorrhages (HICH) were treated with 3D image-guided key-hole microsurgery, and the clinical features were summarized. Preoperative and postoperative hematoma volumes and reduction in midline shifts were calculated and recorded. The preoperative and postoperative (initial, discharge, and 180th day after stroke onset) neurological status was assessed by Glasgow Outcome Scale (GOS), Glasgow Coma Scale (GCS), and modified Rankin Scale (mRS) score, respectively. <strong>RESULTS</strong> The range of hematoma volumes of surgical patients was 24-99 ml (median, 50 ml). The median time of CT scan (from the time of the request to navigation finish) was 11 min. Total and near-total (>90%) hematoma evacuation was achieved in 96.9% cases. Compared with the initial state of neurological assessment, there was a significant improvement in MRS and GCS at discharge (P<0.001). After 6 months, 57.1% of patients had achieved functional recovery (GOS 4-5) and 2 patients had died. <strong>CONCLUSIONS</strong> As a minimally invasive technique, image-guided transcortical sulci or transsylvian approach is highly effective for immediate and complete hematoma evacuation.Entities:
Mesh:
Year: 2019 PMID: 31907343 PMCID: PMC6946045 DOI: 10.12659/MSM.918815
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Figure 1(A–C) Photograph of the CT scanner in storage in the imaging examination room of the Neurosurgical Emergency Department.
Figure 2A sample of preoperative navigation to design the trajectory.
Summary of clinical findings in 35 patients.
| General information before admission | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General Information | Clinical outcomes | |||||||||||
| GCS | mRS | GOS | ||||||||||
| No | Age/Gender | MAP (mmHg) | TA (hou) | T-CT (min) | T-O (min) | Initial | 3rd day | Discharge | Initial | Discharge | 6th month | 6th month |
| 1 | 68/F | 140 | 21 | 11 | 105 | 13 | 15 | 15 | 4 | 2 | 2 | 3 |
| 2 | 61/M | 133 | 6.5 | 12 | 95 | 12 | 12 | 14 | 2 | 1 | 1 | 5 |
| 3 | 74/F | 136 | 13 | 21 | 105 | 9 | 13 | 15 | 5 | 4 | 3 | 4 |
| 4 | 70/M | 158 | 5 | 15 | 120 | 12 | 14 | 15 | 4 | 2 | 2 | 2 |
| 5 | 53/F | 170 | 5 | 8 | 90 | 8 | 13 | 15 | 3 | 2 | 2 | 3 |
| 6 | 70/M | 134 | 5 | 9 | 125 | 12 | 13 | 14 | 4 | 3 | 2 | 3 |
| 7 | 43/M | 160 | 4 | 16 | 160 | 9 | 14 | 15 | 5 | 3 | 3 | 4 |
| 8 | 53/M | 178 | 13.5 | 11 | 85 | 13 | 15 | 15 | 5 | 4 | 3 | 4 |
| 9 | 72/F | 146 | 5.5 | 12 | 90 | 8 | 11 | 13 | 5 | 5 | 4 | 3 |
| 10 | 40/M | 152 | 23 | 8 | 100 | 7 | 11 | 12 | 2 | 0 | 0 | 5 |
| 11 | 72/M | 150 | 13 | 11 | 95 | 7 | 12 | 12 | 4 | 5 | 3 | 3 |
| 12 | 57/F | 113 | 11 | 9 | 135 | 8 | 13 | 13 | 3 | 1 | 1 | 5 |
| 13 | 49/M | 144 | 1 | 12 | 200 | 11 | 15 | 15 | 5 | 4 | 3 | 3 |
| 14 | 75/M | 126 | 3 | 9 | 118 | 5 | 5 | – | 5 | 6 | 6 | 1 |
| 15 | 72/M | 130 | 6 | 8 | 100 | 10 | 13 | 13 | 4 | 3 | 3 | 4 |
| 16 | 44/M | 148 | 5 | 16 | 150 | 9 | 14 | 15 | 3 | 3 | 3 | 3 |
| 17 | 59/M | 110 | 14 | 7 | 110 | 12 | 12 | 12 | 4 | 3 | 3 | 3 |
| 18 | 44/F | 100 | 9 | 21 | 75 | 10 | 12 | 12 | 4 | 3 | 3 | 2 |
| 19 | 64/F | 122 | 1.5 | 26 | 95 | 8 | 9 | 11 | 3 | 3 | 6 | 1 |
| 20 | 55/F | 134 | 3 | 13 | 125 | 7 | 15 | 15 | 4 | 2 | 2 | 4 |
| 21 | 53/M | 126 | 5 | 14 | 130 | 8 | 12 | 13 | 5 | 5 | 4 | 4 |
| 22 | 56/M | 118 | 11 | 9 | 105 | 3 | 12 | 15 | 3 | 2 | 2 | 4 |
| 23 | 60/M | 108 | 16 | 11 | 96 | 7 | 11 | 14 | 5 | 4 | 4 | 3 |
| 24 | 65/F | 150 | 17 | 16 | 135 | 12 | 11 | 13 | 3 | 2 | 1 | 5 |
| 25 | 61/M | 194 | 14.5 | 7 | 120 | 9 | 11 | 12 | 3 | 3 | 2 | 4 |
| 26 | 56/M | 110 | 21 | 11 | 85 | 8 | 12 | 14 | 5 | 4 | 3 | 4 |
| 27 | 65/M | 152 | 11.5 | 8 | 90 | 11 | 12 | 14 | 5 | 5 | 4 | 3 |
| 28 | 58/F | 174 | 13.5 | 16 | 95 | 15 | 13 | 15 | 5 | 3 | 3 | 4 |
| 29 | 75/M | 192 | 22 | 21 | 90 | 7 | 15 | 15 | 4 | 3 | 2 | 5 |
| 30 | 73/M | 175 | 23.5 | 35 | 95 | 6 | 13 | 13 | 3 | 3 | 1 | 5 |
| 31 | 63/F | 130 | 17 | 13 | 80 | 7 | 12 | 14 | 4 | 3 | 3 | 4 |
| 32 | 39/F | 198 | 16.5 | 7 | 68 | 7 | 15 | 15 | 4 | 5 | 3 | 4 |
| 33 | 57/F | 186 | 3 | 11 | 135 | 9 | 13 | 15 | 4 | 3 | 3 | 4 |
| 34 | 62/F | 130 | 9.5 | 10 | 85 | 13 | 15 | 15 | 4 | 2 | 2 | 4 |
| 35 | 37/M | 140 | 4 | 13 | 110 | 14 | 15 | 15 | 5 | 4 | 4 | 2 |
TA – time of admission; T-CT – from the time of the request to transmission into PACS and navigation; T-O – time of operation; MAP – mean arterial pressure.
Summary of the detail information on clinical data and CT findings.
| Project group | (Mean±SD)/median/N | Range or ratio | |
|---|---|---|---|
| Age (year) | 59.29±10.97 | 37–75 | |
| Gender | Male | 21(N) | 60% |
| Female | 14(N) | 40% | |
| MAP (mmHg) | 144.77±26.09 | 100–198 | |
| TA (hours) | 11(M) | 1.00–23.50 | |
| CT time (min) | 11(M) | 7–35 | |
| T-O (min) | 100 (M) | 68–200 | |
| Position | Lobar | 13(N) | 37.14% |
| Putaminal | 16(N) | 45.71% | |
| Thalamic | 6(N) | 17.15% | |
| Hematomas | Right hemisphere | 22(N) | 62.86% |
| Left hemisphere | 13(N) | 37.14% | |
| Hematoma shape | Regular | 12(N) | 34.29% |
| Irregular | 15(N) | 42.86% | |
| Uncertain | 8(N) | 22.85% | |
| Hematoma volume (ml) | Initial | 50(M) | 24–99 |
| Residual | 1.4(M) | 0.10–21.90 | |
| Midline shift (3 days after the operation) | 5–8 mm | 17(N) | 48.57% |
| 8–10 mm | 13(N) | 37.14% | |
| >10 mm | 5(N) | 14.29% | |
| GCS score | On admission | 9(N) | 3–15 |
| At discharge | 14(N) | 0–15 | |
| mRS score | On admission | 4(N) | 2–5 |
| At discharge | 3(N) | 0–6 | |
| OS rate after 6 Months | Good function | 20(N) | 57.14% |
| Disability | 10(N) | 28.57% | |
| Vegetative state | 3(N) | 8.57% | |
| Death | 2(N) | 5.72% | |
| DSA | 6(N) | 17.14% | |
M – median; N – number of patients; DSA – digital subtraction angiography.
Preoperative and immediate postoperative CT findings.
| No | HL | HS | HP | IVH | Initial HV (cm3) | Residual HV (cm3) | ER (100%) | Pre-o MS (mm) | Post-o MS (mm) | Pre-o EV (cm3) | Post-o EV (cm3) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Putaminal | 1 | R | 2 | 31 | 0.2 | 99.4 | ++ | − | 48 | 13 |
| 2 | Lobar | 1 | R | 1 | 72 | 1.0 | 98.6 | ++ | + | 115 | 35 |
| 3 | Lobar | 1 | L | 1 | 53 | 2.1 | 96.3 | +++ | + | 63 | 12 |
| 4 | Putaminal | 3 | R | 2 | 64 | 1.5 | 97.7 | + | − | 74 | 24 |
| 5 | Lobar | 1 | R | 2 | 50 | 0.6 | 98.8 | + | + | 89 | 32 |
| 6 | Lobar | 2 | R | 1 | 32 | 1.0 | 96.9 | + | + | 53 | 12 |
| 7 | Thalamic | 3 | R | 1 | 38 | 0.8 | 97.9 | ++ | − | 72 | 25 |
| 8 | Lobar | 3 | L | 1 | 70 | 0.8 | 98.9 | + | − | 225 | 65 |
| 9 | Putaminal | 1 | R | 1 | 37 | 1.0 | 97.3 | ++ | − | 41 | 9 |
| 10 | Putaminal | 2 | R | 1 | 33 | 2.0 | 93.9 | + | + | 48 | 16 |
| 11 | Thalamic | 2 | R | 1 | 57 | 0.7 | 98.8 | ++ | + | 73 | 20 |
| 12 | Lobar | 2 | L | 1 | 28 | 2.5 | 91.1 | + | − | 32 | 19 |
| 13 | Putaminal | 2 | L | 1 | 33 | 1.5 | 95.5 | + | + | 105 | 21 |
| 14 | Thalamic | 3 | R | 2 | 99 | 21.9 | 77.9 | +++ | + | 321 | 104 |
| 15 | Putaminal | 2 | L | 3 | 50 | 1.3 | 97.4 | + | + | 96 | 31 |
| 16 | Putaminal | 2 | R | 1 | 63 | 0.7 | 98.9 | + | − | 114 | 31 |
| 17 | Lobar | 1 | L | 2 | 30 | 2.8 | 90.7 | +++ | + | 70 | 14 |
| 18 | Putaminal | 3 | L | 4 | 60 | 2.6 | 95.7 | ++ | + | 143 | 23 |
| 19 | Thalamic | 3 | L | 2 | 58 | 1.1 | 98.1 | +++ | + | 72 | 26 |
| 20 | Putaminal | 1 | R | 1 | 36 | 2.2 | 93.9 | + | − | 68 | 31 |
| 21 | Putaminal | 2 | R | 1 | 35 | 0.8 | 97.7 | ++ | − | 47 | 32 |
| 22 | Putaminal | 2 | L | 2 | 33 | 1.1 | 96.7 | + | + | 100 | 24 |
| 23 | Thalamic | 1 | R | 1 | 27 | 0.3 | 98.9 | ++ | − | 41 | 10 |
| 24 | Lobar | 1 | R | 1 | 24 | 0.1 | 97.1 | ++ | + | 37 | 11 |
| 25 | Lobar | 2 | R | 1 | 74 | 3.0 | 95.9 | + | + | 108 | 21 |
| 26 | Lobar | 2 | L | 1 | 28 | 1.6 | 94.3 | + | − | 53 | 12 |
| 27 | Putaminal | 2 | R | 1 | 32 | 0.8 | 97.5 | + | − | 88 | 18 |
| 28 | Putaminal | 3 | R | 2 | 70 | 3.2 | 95.4 | + | + | 185 | 37 |
| 29 | Putaminal | 3 | R | 2 | 90 | 5.4 | 94.0 | ++ | − | 306 | 116 |
| 30 | Lobar | 1 | R | 2 | 86 | 5.0 | 94.2 | ++ | + | 203 | 37 |
| 31 | Lobar | 2 | R | 2 | 53 | 2.6 | 95.1 | + | − | 73 | 22 |
| 32 | Putaminal | 2 | L | 2 | 75 | 1.8 | 97.6 | + | − | 156 | 25 |
| 33 | Lobar | 1 | L | 4 | 90 | 15.5 | 82.8 | +++ | − | 221 | 69 |
| 34 | Thalamic | 2 | L | 4 | 24 | 1.3 | 94.6 | + | − | 57 | 31 |
| 35 | Putaminal | 1 | R | 1 | 55 | 1.4 | 97.5 | ++ | + | 61 | 14 |
R – right; L – left; IVH – intraventricuar hemorrhage; HS – hematoma shape; HP – hematoma position; HL – hematoma location; Pre-o – preoperative; Post-o – post-operative; MS – midline shifting. Post-operative midline shifting indicating 24 hours post operation; Post-operative cisternal status indicating 72 hours post operation; Post operative GCS indicating 1 week post operation. IVH: 1=none; 2=single lateral ventricle; 3=bilateral ventricles; 4=all ventricles, including 3rd and 4th ventricle; Hematoma Shape: 1=regular; 2=irregular; 3=between 1 and 2 grade. Midline shifting: − normal, + 5–8 mm, ++ 8–10 mm, +++ >10 mm; EV – edema volume.
Figure 3Preoperative and immediate postoperative CT images in image-guided key-hole evacuation of representative SICH patients (A–F).
Figure 4Mean preoperative edema volume and mean postoperative edema volume.
Incidence of complications.
| Complications | n (%) |
|---|---|
| Pulmonary infection | 3 (8.5) |
| Bleeding recurrence | 1 (2.9) |
| Digestive tract hemorrhage | 5 (14.3) |
| Epilepsy | 1 (2.9) |